Cash and Marketable Securities (Tables)

3 Months Ended

Mar. 31, 2023

Cash and Cash Equivalents [Abstract]

A reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the amount reported within the condensed consolidated statements of cash flows is shown in the table below (in thousands):


	March 31, 2023		March 31, 2022
Cash and cash equivalents	$	74,660	$	171,892
Restricted cash	520		214
Total cash, cash equivalents, and restricted cash at the end of the period	$	75,180	$	172,106

Schedule of Marketable Securities

The amortized cost, gross unrealized holding losses, and fair value of the Company’s marketable securities by major security type at each balance sheet date are summarized in the tables below (in thousands):


	March 31, 2023
	Amortized Cost		Unrealized Holding Losses		Fair Value
Short-term marketable securities:
U.S. agency securities	$	92,947	$	1,222	$	94,169
Corporate debt securities	118,332		113		118,445
Total short-term marketable securities	211,279		1,335		212,614
Long-term marketable securities:
Corporate equity securities	5,100		(3,828)		1,272
Corporate debt securities	—		—		—
Total long-term marketable securities	5,100		(3,828)		1,272
Total	$	216,379	$	(2,493)	$	213,886


	December 31, 2022
	Amortized Cost		Unrealized Holding Losses		Fair Value
Short-term marketable securities:
U.S. agency securities	$	79,347	$	452	$	79,799
Corporate debt securities	123,821		(220)		123,601
Total short-term marketable securities	203,168		232		203,400
Long-term marketable securities:
Corporate equity securities	5,000		(2,924)		2,076
Total long-term marketable securities	5,000		(2,924)		2,076
Total	$	208,168	$	(2,692)	$	205,476

Contractual maturities of the marketable securities at each balance sheet date are as follows (in thousands):


	March 31, 2023		December 31, 2022
Within one year	$	211,279	$	203,168
After one year through five years	—		—
Total	$	211,279	$	203,168